Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Viemed Healthcare (VMD) Interest & Investment Income (2018 - 2025)

Viemed Healthcare filings provide 8 years of Interest & Investment Income readings, the most recent being -$364000.0 for Q4 2025.

  • On a quarterly basis, Interest & Investment Income fell 147.62% to -$364000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.2 million, a 52.32% decrease, with the full-year FY2025 number at -$1.2 million, down 52.32% from a year prior.
  • Interest & Investment Income hit -$364000.0 in Q4 2025 for Viemed Healthcare, up from -$507000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $49000.0 in Q1 2023 to a low of -$507000.0 in Q3 2025.
  • Median Interest & Investment Income over the past 5 years was -$111500.0 (2021), compared with a mean of -$144850.0.
  • Biggest five-year swings in Interest & Investment Income: soared 176.56% in 2023 and later tumbled 1370.0% in 2024.
  • Viemed Healthcare's Interest & Investment Income stood at -$69000.0 in 2021, then surged by 53.62% to -$32000.0 in 2022, then plummeted by 700.0% to -$256000.0 in 2023, then surged by 42.58% to -$147000.0 in 2024, then tumbled by 147.62% to -$364000.0 in 2025.
  • The last three reported values for Interest & Investment Income were -$364000.0 (Q4 2025), -$507000.0 (Q3 2025), and -$132000.0 (Q2 2025) per Business Quant data.